Literature DB >> 31535768

Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate.

G Genovese1,2, R Caorsi3, C Moltrasio1, A V Marzano1,2.   

Abstract

SAPHO syndrome, namely Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis, is a rare autoinflammatory chronic disease presenting with non-infectious inflammatory osteitis, sterile joint inflammation and skin manifestations, including palmoplantar pustulosis and severe acne. The case of a 15-year-old boy affected by SAPHO syndrome and hidradenitis suppurativa (HS) is presented and discussed. Coexistence of these two diseases may represent a therapeutic challenge and this case confirms literature data reporting the efficacy of the combination of methotrexate and adalimumab in SAPHO complicated by HS.
© 2019 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31535768     DOI: 10.1111/jdv.15849

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Biologic Therapy for Hidradenitis Suppurativa Plus Conglobate Acne Associated with SAPHO Syndrome: A Case Report.

Authors:  Kamilija Briede; Skaidra Valiukeviciene; Vesta Kucinskiene; Harald P M Gollnick
Journal:  Acta Derm Venereol       Date:  2020-11-04       Impact factor: 3.875

2.  SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report.

Authors:  Michele Luzzati; Gabriele Simonini; Cesare Filippeschi; Teresa Giani; Sandra Trapani
Journal:  Ital J Pediatr       Date:  2020-11-13       Impact factor: 2.638

Review 3.  New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations.

Authors:  Wei Cheng; Fen Li; Jing Tian; Xi Xie; Jin-Wei Chen; Xiao-Fei Peng; Qi Tang; Yan Ge
Journal:  J Inflamm Res       Date:  2022-04-13

4.  Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review.

Authors:  Muskaan Sachdeva; Patrick Kim; Asfandyar Mufti; Khalad Maliyar; Cathryn Sibbald; Afsaneh Alavi
Journal:  J Cutan Med Surg       Date:  2021-09-29       Impact factor: 2.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.